DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Coherus BioSciences, Inc. (CHRS)
« Back to company indexCHRS Chatter Timeline
Stock Ticker for CHRS
Most Active Tweeters for CHRS
| User | Tweets |
|---|---|
| @Tickeron | 14 |
| @TheMarketsDaily | 5 |
| @1MinuteStock | 5 |
| @AG1L1S | 5 |
| @dakotafinancial | 4 |
Recent Tweets for CHRS
 |
@scrooge_fs An aquisition for stock $CHRS has been executed #pennyStocks #stocks #MergerAgreement #Trade #StockTrading November 19th 2019, 7:11pm |
 |
@Tickeron $CHRS's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/2XC6pQc8nu November 19th 2019, 6:11pm |
 |
@stockmktgenius $CHRS Coherus BioSciences, Inc. #LeaderPullBack Close: 19.61 Liq: $18M https://t.co/PM5S1zW6Uw November 19th 2019, 6:11pm |
 |
@AG1L1S $CHRS opportunity ~17.5$ November 19th 2019, 9:11am |
 |
@bbnsnews Coherus Biosciences Inc $CHRS COO Sells $48,150.00 in Stock https://t.co/dmDFVPZFsN November 19th 2019, 5:11am |
 |
@sahajpancholia RT @larrywabrams: $CHRS biosimilar to Humira now scheduled to be the EIGHT biosimilar launched in 2023. Maybe CHRS can get 3% in 2024 -- $4… November 18th 2019, 10:11pm |
 |
@AmericanBanking Coherus Biosciences Inc $CHRS COO Sells $48,150.00 in Stock https://t.co/3tqxw6Yi3X #stocks November 18th 2019, 6:11pm |
 |
@dakotafinancial Coherus Biosciences Inc $CHRS COO Sells $48,150.00 in Stock https://t.co/xZBN9gekXU November 18th 2019, 6:11pm |
|
@Tickeron $CHRS enters an Uptrend because Momentum Indicator exceeded the 0 level on November 7, 2019. View odds for this and… https://t.co/iIFnhLWMmD November 18th 2019, 5:11pm |
 |
@ConsumerFeed Coherus Biosciences COO Vincent Anicetti Sells $48,150.00 in $CHRS https://t.co/7fSBSNam9v November 18th 2019, 5:11pm |
 |
@larrywabrams $CHRS biosimilar to Humira now scheduled to be the EIGHT biosimilar launched in 2023. Maybe CHRS can get 3% in 2024… https://t.co/PZijSwwYse November 18th 2019, 3:11pm |
 |
@SwingTradeBot Rose Above 50 DMA today: $CHRS $PBFS ... https://t.co/qwiJH6vr1O November 18th 2019, 2:11pm |
 |
@EnterpriseLeade Short Interest in Coherus Biosciences Inc $CHRS Expands By 5.5% https://t.co/83NX2Usqxw November 18th 2019, 10:11am |
 |
@TranscriptDaily Short Interest in Coherus Biosciences Inc $CHRS Expands By 5.5% https://t.co/1MMPDCVNaY November 18th 2019, 10:11am |
|
@Tickeron $CHRS enters an Uptrend because Momentum Indicator exceeded the 0 level on November 7, 2019. View odds for this and… https://t.co/9a4c7AT2yE November 17th 2019, 5:11pm |
 |
@1MinuteStock Wondering about risks of $CHRS? The 21-day volatility is 19.71% https://t.co/KctqISSBuC November 16th 2019, 9:11pm |
|
@Tickeron $CHRS enters an Uptrend as Momentum Indicator exceeded the 0 level on November 7, 2019. View odds for this and othe… https://t.co/HRqtdPaisY November 16th 2019, 5:11pm |
|
@AmericanBanking Coherus Biosciences Inc $CHRS Short Interest Up 5.5% in October https://t.co/NByWmVTBmQ #stocks November 16th 2019, 4:11pm |
 |
@TheMarketsDaily Coherus Biosciences Inc $CHRS Short Interest Up 5.5% in October https://t.co/zLhvL4Tu1r November 16th 2019, 4:11pm |
 |
@stocknewstimes Coherus Biosciences Inc $CHRS Short Interest Up 5.5% in October https://t.co/kgmkfvpY7C November 16th 2019, 4:11pm |
|
@Tickeron $CHRS's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/LQ614XRppx November 15th 2019, 6:11pm |
|
@larrywabrams @StanMehr $CHRS CEO never talks much about distribution of it’s exit 3Q19 share of 20% between 340B, Part B, and co… https://t.co/aDuAUy4zYZ November 15th 2019, 11:11am |
|
@larrywabrams $CHRS will have a new #biosimilar competition from $NVS Sandoz. Will have to fight very hard to reach and maintain… https://t.co/xdqZ2llZIQ November 15th 2019, 10:11am |
 |
@tradersreport RT @Tickeron: $CHRS in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/N4CKAUjEYo #Coheru… November 14th 2019, 6:11pm |
|
@Tickeron $CHRS in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/uv6hX42Lzj November 14th 2019, 6:11pm |
 |
@StockflareUS $CHRS: Coherus Biosciences Inc's forecast earnings moved 14.5% over the last week, but the price is 1.1%. It's PE r… https://t.co/pRVZen8iB2 November 14th 2019, 4:11am |
|
@Tickeron $CHRS in Uptrend: Stochastic indicator remains in overbought zone for 1 day. View odds for this and other indicator… https://t.co/VkkWPy9iJo November 13th 2019, 5:11pm |
|
@SwingTradeBot Rose Above 50 DMA today: $CHRS $BCTF ... https://t.co/qwiJH6vr1O November 13th 2019, 3:11pm |
 |
@BlueBioNow $CHRS definitely going to finish over $20.96 3.36 % change recently https://t.co/6Uy5xvxSVH November 13th 2019, 2:11pm |
 |
@Gambiste1 RT @kshahi: $CHRS upcoming catalyst by year end (filing Lucentis biosimilar ) should get a nice a sp boost. November 13th 2019, 1:11pm |
 |
@kshahi $CHRS upcoming catalyst by year end (filing Lucentis biosimilar ) should get a nice a sp boost. November 13th 2019, 10:11am |
|
@SwingTradeBot 50 DMA Resistance today: $PTE $CHRS ... https://t.co/mnYaiRq1wk November 13th 2019, 10:11am |
 |
@1stOncology #CoherusBioSciences Management to Present at Two Upcoming Investor #HealthcareConferences $CHRS https://t.co/hUPzWU9AzY November 13th 2019, 7:11am |
|
@BlueBioNow $CHRS exactly don't sell -2.66 % change recently https://t.co/6Uy5xvxSVH November 13th 2019, 1:11am |
|
@Tickeron $CHRS's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/dnwuuDTBro November 12th 2019, 5:11pm |
 |
@newsfilterio [Amend] Statement of acquisition of beneficial ownership by individuals filed with the SEC 4 days ago $CHRS https://t.co/MH1xtvzAAI November 12th 2019, 1:11pm |
|
@AmericanBanking Analysts’ Recent Ratings Changes for Coherus Biosciences $CHRS https://t.co/hfJWl0ei4W #stocks November 12th 2019, 1:11pm |
|
@dakotafinancial Analysts’ Recent Ratings Changes for Coherus Biosciences $CHRS https://t.co/Cv7LsWP5tt November 12th 2019, 12:11pm |
 |
@otcdynamics $CHRS Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences https://t.co/GklGwsWCdP November 12th 2019, 9:11am |
|
@newsfilterio Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences $CHRS https://t.co/cx9SKKqldZ November 12th 2019, 9:11am |
 |
@dispatchtribune Coherus Biosciences $CHRS Earns Buy Rating from Credit Suisse Group https://t.co/zu3eKiWxZn November 12th 2019, 1:11am |
 |
@OlympiaReport Coherus Biosciences $CHRS Earns Buy Rating from Credit Suisse Group https://t.co/aCHLxiCim3 November 12th 2019, 1:11am |
 |
@dailypoliticaln Credit Suisse Group Reaffirms “Buy” Rating for Coherus Biosciences $CHRS https://t.co/Ihq5KFb0jS November 11th 2019, 9:11pm |
|
@Tickeron $CHRS's 10-day Moving Average crossed below its 50-day Moving Average on October 9, 2019. View odds for this and ot… https://t.co/9ESmyDWCJ1 November 11th 2019, 5:11pm |
 |
@ThisLincolnian Coherus Biosciences $CHRS Upgraded to C- by TheStreet https://t.co/89MZdPuTPx November 11th 2019, 3:11am |
 |
@WeekHerald Coherus Biosciences $CHRS Upgraded to C- by TheStreet https://t.co/5B7JYU342D November 11th 2019, 3:11am |
|
@EnterpriseLeade Brokerages Anticipate Coherus Biosciences Inc $CHRS to Announce $0.58 EPS https://t.co/oLpe2yR8tZ November 10th 2019, 9:11pm |
|
@OlympiaReport Coherus Biosciences Inc $CHRS Expected to Announce Quarterly Sales of $117.04 Million https://t.co/56zVdkemiV November 10th 2019, 9:11pm |
|
@TranscriptDaily Analysts Expect Coherus Biosciences Inc $CHRS Will Post Earnings of $0.58 Per Share https://t.co/7VWNfIgj1I November 10th 2019, 9:11pm |
|
@dispatchtribune Brokerages Anticipate Coherus Biosciences Inc $CHRS Will Announce Quarterly Sales of $117.04 Million https://t.co/XTiOkPRe70 November 10th 2019, 9:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.